Aphria

The cover story in this weekend's Barron's suggests ways investors can play the shifting retail landscape. Other featured articles discuss why utility stocks still make sense and how a climate scientist invests for retirement. Also, the prospects for a post-split tech giant, the iPhone...

Canadian medical marijuana company Aphria Inc (NYSE: APHA) is expanding its footprint both internationally and with its portfolio. The company announced plans to acquire CC Pharma GmbH, a German distributor of pharmaceutical products. The deal is valued at the U.S. dollar equivalent of $55...

Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited—get your tickets before they sell out. Ahead of...

April 20 of each year marks a celebration for marijuana enthusiasts, despite the herb still being illegal in most of the country. For investors, what this means is until marijuana becomes legalized at the federal level, you'll be hard pressed to find many pot stocks trading in New York....